RecruitingNot ApplicableNCT05719779

Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Oropharyngeal Cancer.

Evaluation of the Tolerance and Benefits of Mandibular Advanced Device for Snoring and Sleep Apnea in Patients With Oropharyngeal Cancer: Mixed Design Study.

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Enrollment

35 participants

Start Date

Feb 3, 2023

Study Type

INTERVENTIONAL

Conditions

Oral Cancer Pharynx Cancer Sleep Apnea Snoring Oral Squamous Cell Carcinoma

Summary

Evaluation of the Tolerance and Benefits of Mandibular Advanced Device (MAD) for Snoring and Sleep Apnea in Patients with Oropharyngeal Cancer (OPC): Mixed Design Study.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria5

oropharyngeal cancer diagnosis
years of age and over
female or male; ratio of 1/4 toward men
had received RTH in the Department of Radiation Oncology,
reporting snoring and/or respiratory cessation complaints during sleep,

Exclusion Criteria10

pregnant or breastfeeding woman;
edentation preventing retention of the oral appliance;
taking opioid or anxiolitic type medications;
history of major depression,
uncontrolled hypertension,
history of stroke;
under treatment with CPAP for sleep apnea;
regular and intense orofacial pain;
under pharmacological treatment for insomnia;
excessive alcohol or drug use (e.g., cannabis, opioid).

Interventions

DEVICERonco-Onco and MAD

Comparison of active over a neutral mandibular advacement oral appliance to assess tolerance and efficacy in oropharyngeal cancer individuals in managing snoring and sleep apnea following radiotherapy of oropharynx.